Progenics Pharmaceuticals Inc. EBITDA Margin 2010-2020 | PGNX

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Progenics Pharmaceuticals Inc. (PGNX) over the last 10 years. The current EBITDA margin for Progenics Pharmaceuticals Inc. as of March 31, 2020 is .
EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2020-03-31 $0.04B $-0.06B -164.86%
2019-12-31 $0.04B $-0.06B -182.86%
2019-09-30 $0.02B $-0.05B -195.65%
2019-06-30 $0.02B $-0.05B -236.36%
2019-03-31 $0.02B $-0.05B -300.00%
2018-12-31 $0.02B $-0.04B -280.00%
2018-09-30 $0.02B $-0.06B -400.00%
2018-06-30 $0.01B $-0.05B -378.57%
2018-03-31 $0.01B $-0.05B -415.38%
2017-12-31 $0.01B $-0.06B -475.00%
2017-09-30 $0.01B $-0.05B -369.23%
2017-06-30 $0.06B $0.00B 4.69%
2017-03-31 $0.07B $0.01B 18.84%
2016-12-31 $0.07B $0.02B 23.19%
2016-09-30 $0.07B $0.01B 18.84%
2016-06-30 $0.02B $-0.03B -212.50%
2016-03-31 $0.01B $-0.04B -410.00%
2015-12-31 $0.01B $-0.04B -487.50%
2015-09-30 $0.00B $-0.04B -2150.00%
2015-06-30 $0.04B $0.00B 9.30%
2015-03-31 $0.04B $0.01B 11.90%
2014-12-31 $0.04B $0.01B 13.64%
2014-09-30 $0.05B $0.01B 18.75%
2014-06-30 $0.01B $-0.04B -542.86%
2014-03-31 $0.01B $-0.04B -487.50%
2013-12-31 $0.01B $-0.04B -512.50%
2013-09-30 $0.01B $-0.03B -235.71%
2013-06-30 $0.01B $-0.03B -242.86%
2013-03-31 $0.01B $-0.03B -228.57%
2012-12-31 $0.01B $-0.03B -242.86%
2012-09-30 $0.01B $-0.04B -628.57%
2012-06-30 $0.01B $-0.04B -366.67%
2012-03-31 $0.08B $0.02B 26.19%
2011-12-31 $0.08B $0.01B 15.48%
2011-09-30 $0.08B $0.01B 5.95%
2011-06-30 $0.08B $-0.00B -1.25%
2011-03-31 $0.01B $-0.07B -887.50%
2010-12-31 $0.01B $-0.07B -837.50%
2010-09-30 $0.02B $-0.05B -208.70%
2010-06-30 $0.03B $-0.04B -165.38%
2010-03-31 $0.03B $-0.04B -148.28%
2009-12-31 $0.05B $-0.03B -54.17%